Financials data is unavailable for this security.
View more
Year on year IOL Chemicals and Pharmaceuticals Ltd 's revenues fell -3.80% from 22.17bn to 21.33bn. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 1.39bn to 1.34bn, a -3.39% decrease.
| Gross margin | 33.96% |
|---|---|
| Net profit margin | 5.72% |
| Operating margin | 6.95% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, IOL Chemicals and Pharmaceuticals Ltd increased its cash reserves by 453.24%, or 63.00m. The company earned 2.90bn from its operations for a Cash Flow Margin of 13.60%. In addition the company used 1.91bn on investing activities and also paid 925.00m in financing cash flows.
| Cash flow per share | 31.50 |
|---|---|
| Price/Cash flow per share | 15.30 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -3.39%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| Div yield(5 year avg) | 1.07% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 0.00% |
| EPS growth(5 years) | -11.47 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -21.10 |
More ▼
